Hannestad, Ulf, Apostolou, Eirini, Sjögren, Per et al. · Frontiers in medicine · 2023 · DOI
This study found that people with ME/CFS who caught COVID-19 showed signs of a dormant virus (adenovirus) waking up in their mouth and throat. The researchers compared saliva samples from ME/CFS patients and healthy people, and only the ME/CFS patients showed this reactivation after COVID-19 infection. This suggests that ME/CFS patients may have a weakened immune system that cannot keep these latent viruses under control when faced with a new infection like COVID-19.
Understanding viral reactivation patterns in ME/CFS may explain why some patients experience symptom exacerbation following acute infections like COVID-19. These findings could identify a subgroup of ME/CFS patients who might benefit from antiviral therapies targeting adenovirus or immune-modulating treatments. This research provides molecular evidence supporting the immune dysfunction hypothesis in ME/CFS and highlights post-COVID infection as a potential trigger for disease progression.
This study does not prove that adenovirus reactivation causes ME/CFS symptoms or that treating adenovirus will improve ME/CFS outcomes. The research demonstrates correlation and reactivation patterns but does not establish causation or whether the detected antibodies reflect active viral replication. The findings apply specifically to the oral mucosa and may not generalize to systemic pathology or all ME/CFS patient populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.